In this study, we showed that the ATM inhibitor AZD1390 in combination with radiation can induce T1IFN-mediated antitumoral immune responses in otherwise immunologically suppressed pancreatic cancer. The gene discussed is ATM; the disease is pancreatic neoplasm.